Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis

European Journal of Neurology

Volumn 20, Issue 5, 2013, Pages 803-811

  Young, K L ^a   Brandt, A U ^b   Petzold, A ^c   Reitz, L Y ^a   Lintze, F ^a   Paul, F ^b   Martin, R ^a,d   Schippling, S ^a,d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Atrophy; Brain parenchymal fraction; Multiple sclerosis; Optical coherence tomography; Retinal nerve fibre layer

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN DAMAGE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; GREY MATTER DAMAGE; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA NERVE CELL; WHITE MATTER;

ADULT; ATROPHY; AXONS; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; NEUROIMAGING; PROSPECTIVE STUDIES; RETINAL NEURONS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84876331426     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12070     Document Type: Article

References (34)

1. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-399.
2. Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999; 12: 295-302.
3. Vogt J, Paul F, Aktas O, et al. Lower motor neuron loss in multiple sclerosis. Ann Neurol 2009; 66: 310-322.
4. DeLuca GC, Williams K, Evangelou N, Ebers GC, Esiri MM. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 2006; 129: 1507-1516.
5. De Stefano N, Iannucci G, Sormani MP, et al. MR correlates of cerebral atrophy in patients with multiple sclerosis. J Neurol 2002; 249: 1072-1077.
6. Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 2009; 132: 628-634.
7. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131: 808-817.
8. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002; 125: 1676-1695.
9. Kappos L, Moeri D, Radue EW, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Lancet 1999; 353: 949-969.
10. Rudick RA, Fischer E, Lee JC, Simon J, Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 1999; 53: 1698-1704.
11. De Stefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121: 1469-1477.
12. Fisher E, Rudick RA, Simon JH, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002; 59: 1414-1420.
13. Bielekova B, Kadom N, Fisher E, et al. MRI as a marker for disease heterogeneity in multiple sclerosis. Neurology 2005; 65: 1071-1076.
14. Barkhof F, Calabresi PA, Miller DH, Reingold SC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009; 5: 256-266.
15. Khoury S, Bakshi R. Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis. Ann Neurol 2010; 98: 778-779.
16. Petzold A, de Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2010; 9: 921-932.
17. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69: 1603-1609.
18. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68: 1488-1494.
19. Siger M, Dziegielewski K, Jasek L, et al. Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol 2008; 225: 1555-1560.
20. Frohman EM, Dwyer MG, Frohman T, et al. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci 2009; 282: 96-105.
21. Dörr J, Wernecke K, Bock M, et al. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS ONE 2001; 6: e18132.
22. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 2009; 50: 3432-3437.
23. Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci 2008; 268: 12-17.
24. Polman CH, Reingold SC, Edgan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 2005; 58: 840-860.
25. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
26. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122: 871-882.
27. Smith S. Fast robust automated brain extraction. Hum Brain Mapp 2002; 17: 143-155.
28. Smith S, Beckmann C, Ramnani N, et al. Variability in FMRI: a re-examination of intersession differences. Hum Brain Mapp 2004; 45: 1716-1724.
29. Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci 2004; 45: 1716-1724.
30. Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Meth Instrum Comput 2007; 39: 1751-1791.
31. Riccitelli G, Rocca MA, Pagani E, et al. Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. Mult Scler 2012; 18: 1027-1037.
32. Brandt AU, Oberwahrenbrock T, Ringelstein M, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134: 518-533.
33. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 2010; 133: 1591-1601.
34. Saidha S, Ibrahim MA, Eckstein C, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134: 518-533.